Company HLS Therapeutics Inc Toronto S.E.
Equities
AM
CA05328X1015
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 80 | 100.0 % | 85 | 100.0 % | +6.38% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
62.3
%
| 48 | 60.2 % | 53 | 62.3 % | +10.03% |
United States
29.3
%
| 25 | 31.8 % | 25 | 29.3 % | -2.12% |
Rest of World
8.4
%
| 6 | 7.9 % | 7 | 8.4 % | +12.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 56 | 30/04/23 |
John Hanna
DFI | Director of Finance/CFO | - | 21/06/23 |
Ryan Lennox
CMP | Compliance Officer | 43 | 06/05/18 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/05/14 |
Brian Walsh
PRN | Corporate Officer/Principal | - | 31/05/23 |
Patricia Perry
HRO | Human Resources Officer | 48 | 30/06/19 |
David Spence
AUD | Comptroller/Controller/Auditor | 56 | 31/12/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Welborn
CHM | Chairman | 46 | 17/06/21 |
Laura Brege
BRD | Director/Board Member | 66 | 20/03/19 |
John Hanna
DFI | Director of Finance/CFO | - | 21/06/23 |
Craig Millian
CEO | Chief Executive Officer | 56 | 30/04/23 |
Rodney Hill
BRD | Director/Board Member | 56 | 11/03/18 |
Norma Beauchamp
BRD | Director/Board Member | 62 | 31/12/20 |
Kyle Dempsey
BRD | Director/Board Member | 35 | 28/11/22 |
Christian Roy
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,886,247 | 31,730,547 ( 99.51 %) | 0 | 99.51 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+15.05% | 69.5B | |
-1.82% | 24.09B | |
+8.13% | 8.2B | |
-18.28% | 7.97B | |
-0.98% | 7.84B | |
+19.12% | 4.32B | |
0.00% | 4.19B | |
-3.30% | 3.89B | |
+23.97% | 3.62B |